Emergency Department and Infectious Diseases Unit, Hospital Clínic, University of Barcelona, Barcelona, Spain.
J Infect. 2013 Oct;67(4):282-7. doi: 10.1016/j.jinf.2013.06.003. Epub 2013 Jun 14.
To determine the epidemiology of bacteraemic Catheter-Acquired Urinary Tract Infection (CA-UTI) and to identify independent predictors of mortality.
This study was part of a bloodstream infection surveillance study that prospectively collected data on consecutive patients with bacteraemia in our institution from 1991 to 2010. Factors associated with 30-day mortality were determined.
CA-UTI was the confirmed source of 1007 bacteraemias. The most common microorganisms isolated were Escherichiacoli (42%), Klebsiella spp (15%), Enterococcus faecalis (12%) and Pseudomonas aeruginosa (12%). Along the 2006-2010 periods, antibiotic-resistant E. coli and Klebsiella spp isolates accounted for 49% of the bacteraemia due to CA-UTI. Shock and mortality accounted for 125 and 92 cases, respectively (12% and 9%). Factors associated with mortality were: inappropriate empirical treatment (OR: 1.86, 95% CI: 1.48-2.44), ultimately or rapidly fatal prognosis of underlying disease (OR: 2.56, 95% CI: 1.48-4.44) and shock on presentation (OR: 12.62, 95% CI: 7.61-20.95). Inappropriate empirical treatment was most frequent in cases of bacteraemia produced by antibiotic-resistant E. coli or Klebsiella spp, Enterococcus spp. and P. aeruginosa. Factors associated with the isolation of a microorganism of this type were previous antibiotic therapy and healthcare-associated bacteraemia (OR: 1.50, 95% CI: 1.16-2.14 and OR: 3.03, 95% CI: 2.22-4.01, respectively).
In cases of previous antibiotic therapy or healthcare-associated bacteraemic CA-UTI may indicate the need to initiate empirical therapy activity against antibiotic-resistant Enterobacteriaceae, E. faecalis and P. aeruginosa.
确定血源性导管相关性尿路感染(CA-UTI)的流行病学情况,并确定其病死率的独立预测因子。
本研究为血流感染监测研究的一部分,该研究于 1991 年至 2010 年连续前瞻性收集我院血培养阳性患者的资料。确定与 30 天病死率相关的因素。
CA-UTI 是 1007 例菌血症的明确感染源。最常见的分离微生物为大肠埃希菌(42%)、克雷伯菌属(15%)、粪肠球菌(12%)和铜绿假单胞菌(12%)。在 2006-2010 年期间,CA-UTI 导致的血培养阳性中,对 49%的分离大肠埃希菌和克雷伯菌属菌株具有耐药性。休克和死亡分别占 125 例和 92 例(12%和 9%)。与病死率相关的因素包括:经验性治疗不恰当(比值比:1.86,95%可信区间:1.48-2.44)、基础疾病最终或快速预后不良(比值比:2.56,95%可信区间:1.48-4.44)和就诊时休克(比值比:12.62,95%可信区间:7.61-20.95)。经验性治疗不恰当在由耐药性大肠埃希菌或克雷伯菌属、肠球菌属和铜绿假单胞菌引起的血培养阳性中最为常见。与分离此类微生物相关的因素包括先前的抗生素治疗和与医疗保健相关的菌血症(比值比:1.50,95%可信区间:1.16-2.14 和比值比:3.03,95%可信区间:2.22-4.01)。
对于有先前抗生素治疗史或与医疗保健相关的血源性 CA-UTI 患者,可能需要开始针对耐药性肠杆菌科、粪肠球菌和铜绿假单胞菌的经验性治疗活动。